✦ LIBER ✦

MP-22.16: Characteristic in long term survival patient with prostate cancer managed by androgen suppression therapy

✍ Scribed by Y.J. Seo; K.S. Sim; J.M. Heo; U. Kim

Book ID: 116946268
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 65 KB
Volume: 68
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2006.08.1102

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

15 Long Term Androgen Deprivation Therap

15 Long Term Androgen Deprivation Therapy Improves Survival in Prostate Cancer Patients with a Presenting PSA Above 20

✍ E. Berthelet; T. Picklesz; P. Truong; M. Liu; K.W.J. Lee 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Routine long-term androgen suppression f

Routine long-term androgen suppression following standard radiotherapy improves disease-free survival in men with unfavourable-prognosis prostate cancer compared with relapse-initiated therapy

✍ Pirkko Kellokumpu-Lehtinen; Tapio Tulijoki 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Long-term response to combination therap

Long-term response to combination therapy with estramustine and somatostatin analogue in a patient with androgen ablation-refractory prostate cancer

✍ Costantino Cerulli; Alessandro Sciarra; Gianfilippo Salvatori; Franco Di Silveri 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Phase II Study of Long-Term Androgen Sup

Phase II Study of Long-Term Androgen Suppression With Bevacizumab and Intensity-Modulated Radiation Therapy (IMRT) in High-Risk Prostate Cancer

✍ Jacqueline Vuky; Huong T. Pham; Sarah Warren; Erika Douglass; Kasra Badiozamani; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 248 KB

Short- vs long-term androgen suppression

Short- vs long-term androgen suppression plus external beam radiation therapy and survival in men of advanced age with node-negative high-risk adenocarcinoma of the prostate

✍ Anthony V. D'Amico; James W. Denham; Michel Bolla; Laurence Collette; David S. L 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Abstract ## BACKGROUND The study evaluated whether the use of 3 years as compared with 6 months of androgen suppression therapy (AST) combined with external beam radiation therapy (RT) in the treatment of high‐risk prostate cancer was associated with prolonged survival in advanced age men. ##

Adding androgen suppression to radiother

Adding androgen suppression to radiotherapy may improve disease-free survival over radiotherapy alone in locally advanced prostate cancer: Abstracted from: Bolla M, Collette L, Blank L et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 2002; 360: 103–6.

✍ John B Fiveash 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB